000			01930 a2200505 4500
005			20250517025716.0
264		0	_c20160802
008			201608s 0 0 eng d
022			_a1469-0691
024	7		_a10.1016/j.cmi.2015.03.021 _2doi
040			_aNLM _beng _cNLM
100	1		_aHan, Y
245	0	0	_aPrediction of virological response by pretreatment hepatitis B virus reverse transcriptase quasispecies heterogeneity: the advantage of using next-generation sequencing. _h[electronic resource]
260			_bClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases _cAug 2015
300			_a797.e1-8 p. _bdigital
500			_aPublication Type: Comparative Study; Evaluation Study; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAntiviral Agents _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aGenetic Variation
650	0	4	_aHepatitis B virus _xenzymology
650	0	4	_aHepatitis B, Chronic _xdrug therapy
650	0	4	_aHigh-Throughput Nucleotide Sequencing
650	0	4	_aHumans
650	0	4	_aLamivudine _xtherapeutic use
650	0	4	_aMale
650	0	4	_aPrognosis
650	0	4	_aRNA-Directed DNA Polymerase _xgenetics
650	0	4	_aROC Curve
650	0	4	_aRetrospective Studies
650	0	4	_aSequence Analysis, DNA
650	0	4	_aTreatment Outcome
650	0	4	_aViral Load
700	1		_aGong, L
700	1		_aSheng, J
700	1		_aLiu, F
700	1		_aLi, X-H
700	1		_aChen, L
700	1		_aYu, D-M
700	1		_aGong, Q-M
700	1		_aHao, P
700	1		_aZhang, X-X
773	0		_tClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases _gvol. 21 _gno. 8 _gp. 797.e1-8
856	4	0	_uhttps://doi.org/10.1016/j.cmi.2015.03.021 _zAvailable from publisher's website
999			_c24812928 _d24812928